Exagen Inc.
XGN
Positions held
Your positionsXGN isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $197.92M | Enterprise value | $200.99M | Trailing P/E | — | Forward P/E | -17.38 |
| PEG | — | Price / book | 16.18 | Beta | 2.12 | Dividend yield | 0.00% |
| Revenue growth | 15.9% | Earnings growth | — | Gross margin | 58.6% | Operating margin | -8.6% |
| Profit margin | -26.6% | ROE | -113.8% | ROA | -14.9% | Debt / equity | 2.26 |
| Current ratio | 3.19 | Free cash flow | -$1.56M | Analyst recommendation | none | Mean target | $10.14 |
| 52w high | $12.23 | 52w low | $2.59 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $19.9M | $17.3M | $16.6M | $17.2M | $17.2M |
| Op margin | -8.6% | -19.7% | -29.9% | -18.0% | -15.3% |
| Net income | -$3.2M | -$4.0M | -$4.7M | -$7.1M | -$4.4M |
| Gross margin | 61.3% | 59.0% | 55.4% | 58.4% | 60.4% |
| Gross profit | $12.2M | $10.2M | $9.2M | $10.1M | $10.4M |
| Operating income | -$1.7M | -$3.4M | -$5.0M | -$3.1M | -$2.6M |
- Revenue +15% vs prior quarter ($20M vs $17M).
- Gross margin 61.3% (was 59% prior quarter).
- Operating margin expanded to -8.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $66.6M | $55.6M | $52.5M | $45.6M | — |
| Op margin | -21.1% | -24.5% | -43.5% | -89.0% | — |
| Net income | -$20.0M | -$15.1M | -$23.7M | -$47.4M | — |
| Gross margin | 58.3% | 59.5% | 56.1% | 46.9% | — |
| Gross profit | $38.8M | $33.1M | $29.5M | $21.3M | — |
| Operating income | -$14.1M | -$13.6M | -$22.8M | -$40.5M | — |
Headlines — positive tone
• [OK · fundamentals] Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Path to Profitability
News
2026-08-11 · Exagen (XGN) Q2 2026 Earnings Call Transcript
2026-08-06 · Exagen (XGN) Stock Gets Fair Value Boost As Analysts Weigh Growth And Execution
2026-08-05 · B. Riley Adjusts Price Target on Exagen to $12 From $8, Maintains Buy Rating
2026-08-04 · Exagen Inc. Q2 2026 Earnings Call Summary
2026-08-04 · Exagen Inc (XGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Path to Profitability
2026-08-04 · Exagen Q2 Earnings Call Highlights
2026-08-04 · Exagen Reports Record Second-Quarter 2026 Revenue and Raises Full-Year Guidance
2026-08-04 · Exagen Inc. (XGN) Reports Q2 Loss, Beats Revenue Estimates
2026-08-04 · Exagen Inc. Reports Second Quarter 2026 Financial Results
2026-07-28 · Exagen Inc. to Participate in Upcoming Investor Conference
2026-07-21 · Exagen to Announce Second Quarter Financial Results on August 4, 2026
Price (daily)
Full chart · RSI · MACD · patterns